Efficacy of Peripheral Magnetic Stimulation Compare to Dry Needling in Myofascial Pain Syndrome

July 1, 2022 updated by: Apiphan Iamchaimongkol, MD, Mahidol University

Efficacy of Peripheral Magnetic Stimulation Compare to Dry Needling in Patient With Upper Trapezius Myofascial Pain Syndrome

Compare efficiency between repetitive peripheral magnetic stimulation and dry needling in patient with upper trapezius myofascial pain syndrome.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Thailand
      • Bangkok, Thailand
        • Physical Medicine and Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with myofascial pain syndrome at unilateral upper trapezius muscle and had pain score (Visual analog scale) at least 4

Exclusion Criteria:

  • Patients with signs and/or symptoms of neurological deficit
  • Patients with history of cervical hernia, cervical radiculopathy, cervical myelopathy, fibromyalgia, whiplash spondylosis and cervical spinal stenosis.
  • Patients who received physical therapy/injection/surgery at neck or pain area in last 6 months.
  • Patients with abnormal coagulopathy and/or currently use anticoagulant medicine.
  • Patients with cardiac device.
  • Patients with history of aneurysm clip procedure, stent-coils procedure or cochlear implant surgery.
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Repetitive Peripheral Magnetic Stimulation
Repetitive Peripheral Magnetic Stimulation 1 session
Device: Repetitive Peripheral Magnetic Stimulation
Repetitive Peripheral Magnetic Stimulation at trigger point of upper trapezius muscle
Experimental: Dry Needling
Dry Needling 1 session
Procedure: Dry needling
Dry needling at trigger point of upper trapezius muscle

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Visual analog scale
Time Frame: Change from baseline Visual analog scale at immediately after intervention, Change from Baseline visual analog scale at 1 week and Change from baseline Visual analog scale at 4 weeks
Pain measurement Score from 0-10, 0 means no pain and 10 means maximum pain. Higher scores mean worse outcome.
Change from baseline Visual analog scale at immediately after intervention, Change from Baseline visual analog scale at 1 week and Change from baseline Visual analog scale at 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neck disability index
Time Frame: Change from baseline Neck disability index at immediately after intervention, Change from Baseline Neck disability index at 1 week and Change from baseline Neck disability index at 4 weeks
Disability secondary to neck pain Score from 0-50, 0 means no disability and 50 means complete disability. Higher scores mean worse outcome.
Change from baseline Neck disability index at immediately after intervention, Change from Baseline Neck disability index at 1 week and Change from baseline Neck disability index at 4 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain pressure threshold
Time Frame: Change from baseline Pain pressure threshold at immediately after intervention, Change from Baseline Pain pressure threshold at 1 week and Change from baseline Pain pressure threshold at 4 weeks
The minimum pressure that induces pain in trigger point. Higher scores mean better outcome.
Change from baseline Pain pressure threshold at immediately after intervention, Change from Baseline Pain pressure threshold at 1 week and Change from baseline Pain pressure threshold at 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mahidol University

Investigators

  • Study Director: Apiphan Iamchaimongkol, M.D., Mahidol University, Ramathibodi Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 11, 2022

Primary Completion (Actual)

May 1, 2022

Study Completion (Actual)

July 1, 2022

Study Registration Dates

First Submitted

March 25, 2022

First Submitted That Met QC Criteria

April 2, 2022

First Posted (Actual)

April 11, 2022

Study Record Updates

Last Update Posted (Actual)

July 5, 2022

Last Update Submitted That Met QC Criteria

July 1, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AIamchaimongkol

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myofascial Pain Syndrome

Clinical Trials on Repetitive Peripheral Magnetic Stimulation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe